Real-time enrollment status for this neuromyelitis optica clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:33 PM UTC
| NCT Number | NCT07010302 |
| Recruiting Status | Recruiting |
| Condition | Neuromyelitis Optica |
| Phase | PHASE4 |
| Target Enrollment | 540 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | September 24, 2026 (2 weeks ago) |
As of October 12, 2026: Clinical trial NCT07010302 is currently recruiting participants. This phase4 study for neuromyelitis optica is actively seeking new participants at 2 locations across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07010302 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07010302 was last updated 2 weeks ago (September 24, 2026). HelloStudys verifies this status automatically.